Trials / Completed
CompletedNCT06735235
Salivary Fluoride Clearance
Evaluation of Salivary Fluoride Clearance Following the Use of Three MFP-Containing Dentifrices
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Procter and Gamble · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center, four-treatment, four-period crossover study. Over the course of the study, up to thirty qualified subjects will use four (4) study treatment products, one time each according to the randomization. Subjects will brush with 1.25g of the assigned study product at each visit. Subjects will provide saliva samples at baseline and at 2, 6, 12, and 30 minutes post-treatment. The F- concentrations in each saliva sample will be determined by ion chromatography
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0 ppm F | Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study. |
| DRUG | 250 ppm F as MFP | Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study. |
| DRUG | 1100 ppm as MFP | Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study. |
| DRUG | 2800 ppm F as MFP | Each subject will be randomly assigned to this treatment during one of the four periods for this crossover study. |
Timeline
- Start date
- 2021-07-14
- Primary completion
- 2021-07-29
- Completion
- 2021-07-29
- First posted
- 2024-12-16
- Last updated
- 2024-12-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06735235. Inclusion in this directory is not an endorsement.